How Can We Encourage Minorities to Join Cancer Clinical Trials?
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
The injustices come in many ways. A transgender woman is admitted to the hospital for cancer treatment. Her physicians...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
September is Ovarian Cancer Awareness Month. It’s an apt time for the American Association for Cancer Research (AACR) Advances...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...